&nbsp;

Discharge-Letter-Template-Colposcopist-To-Primary-Care-Screening-Cessation-FR.docx

Jan 2025

Document

Discharge-Letter-Template-Colposcopist-To-Patient-FR.docx

Jan 2025

Document

Discharge-Letter-Template-Colposcopist-To-Patient-Hysterectomy-FR.docx

Jan 2025

Document

Discharge-Letter-Template-Colposcopist-To-Patient-Screening-Cessation-FR.docx

Jan 2025

Regimen

DURV

Cancer Type:

Lung,

Small Cell

Intent: Adjuvant

Drugs Used:

durvalumab (Compassionate)

Quick Link(s):

Regimen Monograph

Apr 2025

Regimen

IBRU+RITU

Cancer Type:

Hematologic

Intent: Palliative

Funding:

Exceptional Access Program

iBRUtinib - In Combination with Rituximab for Previously Treated Waldenstrӧms Macroglobulinemia

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - In Combination with Ibrutinib for Previously Treated Waldenstrӧms Macroglobulinemia

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - In Combination with Ibrutinib for Previously Treated Waldenstrӧms Macroglobulinemia

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2025

Regimen

DEXAPOMASELI

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

dexamethasone,

pomalidomide (Unfunded),

selinexor (Unfunded)

Quick Link(s):

Regimen Monograph

May 2025

Regimen

IBRU(MNT)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Drugs Used:

iBRUtinib (Unfunded)

Quick Link(s):

Regimen Monograph

May 2025

Regimen

IBRUVENE

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Drugs Used:

iBRUtinib (Unfunded),

venetoclax (Unfunded)

Quick Link(s):

Regimen Monograph

May 2025

Regimen

DOXOTRBC

Cancer Type:

Sarcoma,

Soft Tissue

Intent: Palliative

Drugs Used:

DOXOrubicin,

trabectedin (Unfunded)

Quick Link(s):

Regimen Monograph

May 2025

Document

ICCU-Cannabis-Poster_AODA.pdf

May 2025

Document